Sunday, September 16, 2018 5:16:10 PM
From past filings with Lex, they have been working on reimbursement for some time and as such I am anticipating that reimbursement will be accomplished shortly after FDA clearance.
Medicare will play a huge role in the sales & use of the HS IMO. Most all of my business is with Medicare age clients so I do contract with CMS and have a thorough understanding of their procedures.
I feel we will see a significant increase with the completion of the trials and submitting to FDA with a slow and steady climb while waiting for clearance.
Clearance I believe will bring the largest increase we have seen thus far.
I feel they will contract the sales to providers with a major medical supplier and hopefully with more than one.
I feel when the news hits of contracts we will again see a significant increase in SP at that point.
As you are indicating though, the biggest jump will come from HS actually being sold & in use with potential dividends on the horizon, with the fullest potential of the SP being realized from actual dividends being paid to us common share holders. (IMO also)
70% of my business hits Oct. 15th & runs to Dec. 7th so soon I won't be able to do much of anything else but work.
Best wishes to us all for a rebound this week.
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM